TERMINATED

Reward-based Technology to Improve OUD Treatment

Conditions

Opioid Use Disorder Substance Use Disorder Contingency Management Medication for opioid use disorder Medication-assisted treatment

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Millions of people in the US misuse opioids each year. Medication assisted treatment (MAT) for opioid use disorder (OUD) is highly efficacious, but only a fraction of OUD persons access MAT, and treatment non-adherence is common and associated with poor outcomes. This project will utilize a digital mobile platform, Opioid Addiction Recovery Support with contingency management (OARSCM), to increase MAT treatment initiation and adherence among OUD patients recruited from emergency departments and inpatient acute care.

Official Title

Reward-based Technology to Improve Opioid Use Disorder Treatment Initiation After an ED Visit - Phase 2

Quick Facts

Study Start:2022-08-22

Study Completion:2025-05-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:TERMINATED

Study ID

NCT05180669

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
1. \>= 18 years old 2. Presenting for acute care at UMass University and Memorial hospitals, including EDs, inpatient medical units, or inpatient behavioral health units for opioid addiction related health complaints, including opioid overdose, opioid related medical consequences, opioid intoxication or withdrawal syndromes, and/or seeking help for OUD 3. Presence of a current DSM-V opioid use disorder (OUD), mild to severe 4. Medically appropriate for outpatient Suboxone treatment, as judged by the treating clinician and behavioral health consultant or toxicologist working with the patient clinically	1. Persistent altered mental status (not alert, not oriented, psychotic). 2. Not interested or willing to participate in Suboxone treatment 3. Best referral site is NOT one of the study's partner clinics in the central MA region, which will be outpatient MAT clinics and primary care within the UMass system and the three other primary facilities outside of the UMass system. 4. Unwilling to use the OARSCM app (if assigned) 5. Does not have access to their own smartphone with at least iOS 7.1 or Android 4.2, the minimal technology required to run the app, or not willing to access clinic-dedicated computer to access the program 6. Currently in state custody or pending legal action that might lead to imprisonment 7. Cannot paraphrase the study requirements 8. Does not read or speak English 9. Does not reside in the central MA region 10. Already enrolled into the trial

Inclusion Criteria

Exclusion Criteria

1. \>= 18 years old
2. Presenting for acute care at UMass University and Memorial hospitals, including EDs, inpatient medical units, or inpatient behavioral health units for opioid addiction related health complaints, including opioid overdose, opioid related medical consequences, opioid intoxication or withdrawal syndromes, and/or seeking help for OUD
3. Presence of a current DSM-V opioid use disorder (OUD), mild to severe
4. Medically appropriate for outpatient Suboxone treatment, as judged by the treating clinician and behavioral health consultant or toxicologist working with the patient clinically

1. Persistent altered mental status (not alert, not oriented, psychotic).
2. Not interested or willing to participate in Suboxone treatment
3. Best referral site is NOT one of the study's partner clinics in the central MA region, which will be outpatient MAT clinics and primary care within the UMass system and the three other primary facilities outside of the UMass system.
4. Unwilling to use the OARSCM app (if assigned)
5. Does not have access to their own smartphone with at least iOS 7.1 or Android 4.2, the minimal technology required to run the app, or not willing to access clinic-dedicated computer to access the program
6. Currently in state custody or pending legal action that might lead to imprisonment
7. Cannot paraphrase the study requirements
8. Does not read or speak English
9. Does not reside in the central MA region
10. Already enrolled into the trial

Contacts and Locations

Principal Investigator

Rachel Davis-Martin, PhD

STUDY_DIRECTOR

University of Massachusetts Chan Medical School

Study Locations (Sites)

UMass Chan Medical School

Worcester, Massachusetts, 01655

United States

Collaborators and Investigators

Sponsor: Q2i, LLC

Rachel Davis-Martin, PhD, STUDY_DIRECTOR, University of Massachusetts Chan Medical School

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-08-22

Study Completion Date2025-05-31

Study Record Updates

Study Start Date2022-08-22

Study Completion Date2025-05-31

Terms related to this study

Keywords Provided by Researchers

Substance Use Disorder
Opioid Use Disorder
Contingency Management
Medication for opioid use disorder
Medication-assisted treatment

Additional Relevant MeSH Terms

Opioid Use Disorder